Apolipoprotein M (apoM) was discovered in 1999 (1) and has since been associated with various conditions, such as atherosclerosis, cardiovascular disease (2), dyslipidemia (3), diabetes (4, 5), inflammation, and sepsis (6). This evidence concerns the gene APOM and atherosclerosis.